Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-651X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience ; day:9 ; month:6 ; year:2021 ; pages:1-12
Pain and therapy ; (9.6.2021), 1-12
- Urheber
-
Silvestro, Marcello
Orologio, Ilaria
Bonavita, Simona
Scotto di Clemente, Fabrizio
Fasano, Carla
Tessitore, Alessandro
Tedeschi, Gioacchino
Russo, Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40122-021-00273-w
- URN
-
urn:nbn:de:101:1-2021100206125405917843
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silvestro, Marcello
- Orologio, Ilaria
- Bonavita, Simona
- Scotto di Clemente, Fabrizio
- Fasano, Carla
- Tessitore, Alessandro
- Tedeschi, Gioacchino
- Russo, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
CGRP and migraine: neurogenic inflammation revisited
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
CGRP-targeted medication in chronic migraine - systematic review
Genetics of Menstrual Migraine: The Epidemiological Evidence
Are Menstrual and Nonmenstrual Migraine Attacks Different?
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP and migraine: neurogenic inflammation revisited
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
CGRP-targeted medication in chronic migraine - systematic review
Genetics of Menstrual Migraine: The Epidemiological Evidence
Are Menstrual and Nonmenstrual Migraine Attacks Different?
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP and migraine: neurogenic inflammation revisited
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
CGRP-targeted medication in chronic migraine - systematic review
Genetics of Menstrual Migraine: The Epidemiological Evidence
Are Menstrual and Nonmenstrual Migraine Attacks Different?
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis